Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

POMALYST for Myelofibrosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where POMALYST was used for Myelofibrosis.

Most Reported Side Effects for POMALYST

Side Effect Reports % Deaths Hosp.
Death 177 12.7% 177 17
Plasma cell myeloma 162 11.6% 105 36
Pneumonia 98 7.0% 17 80
Fatigue 94 6.7% 1 7
Full blood count decreased 51 3.7% 3 25
Dyspnoea 47 3.4% 1 21
Dizziness 38 2.7% 0 2
Neuropathy peripheral 37 2.7% 0 2
Rash 36 2.6% 0 7
Asthenia 35 2.5% 3 10
Pyrexia 35 2.5% 1 18
Adverse drug reaction 34 2.4% 0 1
White blood cell count decreased 34 2.4% 1 9
Drug ineffective 32 2.3% 4 10
Unevaluable event 32 2.3% 3 2

Other Indications for POMALYST

Plasma cell myeloma (1,360) Product used for unknown indication (11)

Other Drugs Used for Myelofibrosis

RUXOLITINIB (21,650) PACRITINIB (1,586) JAKAFI (1,314) FEDRATINIB (682) MOMELOTINIB (526) LENALIDOMIDE (496) THALIDOMIDE (349) DEFERASIROX (150) HYDROXYUREA (129) JAKAVI (98)

Related Pages

POMALYST Full Profile All Myelofibrosis Drugs POMALYST Demographics POMALYST Timeline